Who founded Vellabio?

Vellabio was founded by Nial C. DeMena in 2020.

Who are Vellabio's investors?

Vellabio's investors include Merida Capital Holdings.

How much funding has Vellabio raised?

Vellabio has disclosed $1.6M raised across 1 round.

Where is Vellabio headquartered?

Vellabio is headquartered in Worcester, US.

Vellabio

Worcester, US · Founded 2020 · 12 employees on LinkedIn · 1 known investors

Find your way into Vellabio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vellabio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vella Bioscience develops products for women's sexual and reproductive health using nano-encapsulated liposomal cannabidiol and liposome-based biotech to improve absorption of active ingredients, with a focus on female arousal, orgasm, and related pain. Its work spans the broader landscape of women's sexual and reproductive medicine.

Biotech FemTech Wellness & Fitness

Founders & leadership

Vellabio was founded in 2020 by Nial C. DeMena.

Nial C. DeMena Founder · Board MemberNial C. DeMena is an executive officer and director at Vella Bioscience, which develops cannabidiol-based products for women's sexual and reproductive health. He has founded multiple businesses and has background in business development, operations, and research.

Carolyn WheelerChief Executive Officer

Harin Padma-NathanChief Medical Officer

Michael FridNamed on SEC filing

Julio VegaMr. Vega is the Secretary of the Issuer.

Investors · 1

Merida Capital Holdingslisted by Merida Capital HoldingsRye

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2020

▶$1.6MraisedDec 2020 · 11 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Harin Padma-NathanExecutive Officer, Director
Carolyn WheelerExecutive Officer
Michael FridExecutive Officer
Nial C. DeMenaExecutive Officer, Director, Promoter
Julio VegaExecutive Officer

Offering amount: $5.5M
Amount sold: $1.6M
First sale: Nov 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Vellabio do?: Vella Bioscience develops products for women's sexual and reproductive health using nano-encapsulated liposomal cannabidiol and liposome-based biotech to improve absorption of active ingredients, with a focus on female arousal, orgasm, and related pain. Its work spans the broader landscape of women's sexual and reproductive medicine.
Who founded Vellabio?: Vellabio was founded by Nial C. DeMena in 2020.
Who are Vellabio's investors?: Vellabio's investors include Merida Capital Holdings.
How much funding has Vellabio raised?: Vellabio has disclosed $1.6M raised across 1 round.
Where is Vellabio headquartered?: Vellabio is headquartered in Worcester, US.